Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33391412

Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Cancer
Publication date
2021
First author
Shen QD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Shen QD
      type
      Author
    2. name
      Wang L
      type
      Author
    3. name
      Zhu HY
      type
      Author
    4. name
      Liang JH
      type
      Author
    5. name
      Xia Y
      type
      Author
    6. name
      Wu JZ
      type
      Author
    7. name
      Fan L
      type
      Author
    8. name
      Li JY
      type
      Author
    9. name
      Xu W
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Shen QD
      type
      Author
    2. name
      Wang L
      type
      Author
    3. name
      Zhu HY
      type
      Author
    4. name
      Liang JH
      type
      Author
    5. name
      Xia Y
      type
      Author
    6. name
      Wu JZ
      type
      Author
    7. name
      Fan L
      type
      Author
    8. name
      Li JY
      type
      Author
    9. name
      Xu W
      type
      Author
    bibliography ids
    1. nci-bib-802c6b9f526803070e401736
    book metadata
    content sha256
    9e5fd5f4d5695fe008d726c71df081347e0dc2473faa9aab4c74a0c39bc7f380
    document type
    citation
    dois
    1. 10.7150/jca.47031
    electronic publication date
    display
    2021 Jan 1
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33391412
    immutable id
    pubmed:33391412@9e5fd5f4d5695fe008d726c71df081347e0dc2473faa9aab4c74a0c39bc7f380
    journal
    abbreviation
    J Cancer
    issn electronic
    1837-9664
    issn print
    1837-9664
    issue
    1
    name
    Journal of Cancer
    nlm unique id
    101535920
    pages
    163-169
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33391412
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      f0a44476f54eee0ac772f6b8e47d47d2f3da789dd903f39821102315e29d26cf
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021
      precision
      year
      year
      2021
      publication types
      1. Journal Article
      record status
      PubMed
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33391412/
      title
      Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice